Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Centhaquine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmazz & Dr. Reddy's have entered into a lice agreement to market Centhaquine
    Pharmazz & Dr. Reddy's have entered into a lice agreement to market Centhaquine

    22 Mar 2024

    // PRESS RELEASE

    https://www.drreddys.com/cms/cms/sites/default/files/2024-03/Dr.%20Reddy%27s%20and%20Pharmazz%2C%20Inc.%20enter%20into%20licensing%20agreement%20to%20market%20first-in-class%20Centhaquine%20%28Lyfaquin%C2%AE%29%20for%20hypovolemic%20shock%20in%20India.pdf

    PRESS RELEASE
    22 Mar 2024
    Share Share
    Pharmazz Inc. Presents Data From its Positive Phase III Study of Centhaquine
    Pharmazz Inc. Presents Data From its Positive Phase III Study of Centhaquine

    13 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/13/2514839/0/en/Pharmazz-Inc-Presents-Data-From-its-Positive-Phase-III-Study-of-Centhaquine-PMZ-2010-as-a-Resuscitative-Agent-in-Hypovolemic-Shock-Patients-at-Upcoming-Military-Health-System-Resea.html

    GLOBENEWSWIRE
    13 Sep 2022
    Share Share
    Marketing authorization received for Lyfaquin™ (centhaquine)
    Marketing authorization received for Lyfaquin™ (centhaquine)

    14 May 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/marketing-authorization-received-for-lyfaquin-centhaquine-to-treat-patients-with-hypovolemic-shock-from-indian-regulatory-agency-301059610.html

    PRNEWSWIRE
    14 May 2020
    Share Share